What 23andMe business troubles could mean for millions of users' genetic data
The financial struggles of genetic testing and ancestry company 23andMe are raising questions ... development arm in an attempt to cut costs. On Tuesday, 23andMe released its latest earnings report, showing revenue dipped 12% in the last quarter and ...
Ancestry does not use the standard Y-chromosome ... The app tested 216 populations to generate the report. 23andMe can display the results in a timeline, so you can see approximately how many ...
Millions of people have sent their DNA to be analyzed by 23andMe in order to learn their genealogy and risk for certain ...
Once millions used it to find out about their family histories - this week it was almost delisted. What went wrong?
Best known for its saliva-based test kits that offer a glimpse into a person’s genetic ancestry ... its long-running transparency report. Potential buyers of 23andMe may have entirely different ...
Unlike competitors like Ancestry.com, 23andMe sought to leverage its database for drug discovery. The company went public in 2021 and was valued around $3.5 billion. The funding allowed 23andMe ...
David Paul Morris/Bloomberg/Getty For the last decade, 23andMe has been known worldwide for offering genetic testing, ancestry tracing and health information to its customers. Now the company’s ...
Genetic testing company 23andMe makes it easy to get to know yourself — and your background — better. Reports can offer information on ancestry, familial traits, hereditary disorders ...
The genealogy company’s CEO announced over 200 employees will be let go and it will also shutter its drug-development arm.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback